E
Erik Roys
Researcher at University of Michigan
Publications - 16
Citations - 1696
Erik Roys is an academic researcher from University of Michigan. The author has contributed to research in topics: Kidney disease & End stage renal disease. The author has an hindex of 12, co-authored 16 publications receiving 1614 citations. Previous affiliations of Erik Roys include University of Cologne.
Papers
More filters
Journal ArticleDOI
Quality of life in Chronic Kidney Disease (CKD): A cross-sectional analysis in the Renal Research Institute-CKD study
Rachel L. Perlman,Fredric O. Finkelstein,Lei Liu,Erik Roys,Margaret Kiser,George Eisele,Sally Burrows-Hudson,Joseph M. Messana,Nathan W. Levin,Sanjay Rajagopalan,Friedrich K. Port,Robert A. Wolfe,Rajiv Saran +12 more
TL;DR: SF-36 scores were higher in this CKD cohort compared with hemodialysis patients, but lower than in healthy controls, and GFR was not significantly associated with QOL.
Journal ArticleDOI
Dialysis Dose and Body Mass Index Are Strongly Associated with Survival in Hemodialysis Patients
TL;DR: It is concluded that a higher dialysis dose, substantially above the Dialysis Outcomes Quality Initiative guidelines (URR >65%), is a strong predictor of lower patient mortality for patients in all body-size groups.
Journal ArticleDOI
Trends in Organ Donation and Transplantation in the United States, 1999–2008
TL;DR: In this article, the reference tables in the 2009 OPTN/SRTR Annual Report were used for the analysis of transplant transplant transplantation data, and the results of the analysis were presented.
Journal ArticleDOI
Tailoring the initial vascular access for dialysis patients.
Klaus Konner,Klaus Konner,Tempie E. Hulbert-Shearon,Tempie E. Hulbert-Shearon,Erik Roys,Erik Roys,Friedrich K. Port,Friedrich K. Port +7 more
TL;DR: Results of access survival for age groups <65 and 65+ years, male and female, diabetic and non-diabetic subgroups ranged from 51 to 75% for unassisted and from 75 to 96% for assisted two year access survival and PVF appeared to be advantageous over non-PVF access at the elbow.
Journal ArticleDOI
Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects
George R. Bailie,George Eisele,Lei Liu,Erik Roys,Margaret Kiser,Frederick Finkelstein,Robert R. Wolfe,Friedrich K. Port,Sally Burrows-Hudson,Rajiv Saran +9 more
TL;DR: Substantial underutilization of certain classes of cardioprotective medications is apparent, and systematic educational efforts in this direction may well prove worthwhile to impact outcomes.